GTC Biotherapeutics (fka GTCB)

[croumagnon]

"it is interesting that GTC's 3 main partners are all private companies..."

That is interesting indeed! It implies three possible things to me:

(1) These partners are not directly affected by the marklet gyrations, so our base support is in good shape...
(2) GTCB may be thinking of going the private route once again with the help of one of those partners/// At what price will they take it away from the shareholders is anyone's guess, but I doubt it will be below $1...
(3) A reverse merger with one of these partners in order to take them public easily on the NASDAQ board may be the way to go...

Number (3) above may be the best thing for shareholders in the near-term and it will resolve all our financial problems going forward...